Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1989 1
1990 3
1991 5
1992 3
1993 1
1994 1
1995 2
1996 3
1998 1
2013 2
2014 1
2017 1
2018 1
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group. Feagan BG, et al. N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734. N Engl J Med. 2013. PMID: 23964932 Free article. Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Long-Term Effects of a Web-Based Low-FODMAP Diet Versus Probiotic Treatment for Irritable Bowel Syndrome, Including Shotgun Analyses of Microbiota: Randomized, Double-Crossover Clinical Trial.
Ankersen DV, Weimers P, Bennedsen M, Haaber AB, Fjordside EL, Beber ME, Lieven C, Saboori S, Vad N, Rannem T, Marker D, Paridaens K, Frahm S, Jensen L, Rosager Hansen M, Burisch J, Munkholm P. Ankersen DV, et al. Among authors: rannem t. J Med Internet Res. 2021 Dec 14;23(12):e30291. doi: 10.2196/30291. J Med Internet Res. 2021. PMID: 34904950 Free PMC article. Clinical Trial.
Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis.
Miehlke S, Aust D, Mihaly E, Armerding P, Böhm G, Bonderup O, Fernández-Bañares F, Kupcinskas J, Munck LK, Rehbehn KU, Nacak T, Greinwald R, Münch A; BUG-1/LMC Study Group. Miehlke S, et al. Gastroenterology. 2018 Dec;155(6):1795-1804.e3. doi: 10.1053/j.gastro.2018.08.042. Epub 2018 Sep 7. Gastroenterology. 2018. PMID: 30195447 Free article. Clinical Trial.
Selenium status in patients with Crohn's disease.
Rannem T, Ladefoged K, Hylander E, Hegnhøj J, Jarnum S. Rannem T, et al. Am J Clin Nutr. 1992 Nov;56(5):933-7. doi: 10.1093/ajcn/56.5.933. Am J Clin Nutr. 1992. PMID: 1415013
Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis.
Miehlke S, Madisch A, Kupcinskas L, Petrauskas D, Böhm G, Marks HJ, Neumeyer M, Nathan T, Fernández-Bañares F, Greinwald R, Mohrbacher R, Vieth M, Bonderup OK; BUC-60/COC Study Group. Miehlke S, et al. Gastroenterology. 2014 May;146(5):1222-30.e1-2. doi: 10.1053/j.gastro.2014.01.019. Epub 2014 Jan 15. Gastroenterology. 2014. PMID: 24440672 Free article. Clinical Trial.
Pancreatic function in Crohn's disease.
Hegnhøj J, Hansen CP, Rannem T, Søbirk H, Andersen LB, Andersen JR. Hegnhøj J, et al. Among authors: rannem t. Gut. 1990 Sep;31(9):1076-9. doi: 10.1136/gut.31.9.1076. Gut. 1990. PMID: 1698692 Free PMC article.
Selenoprotein P in patients on home parenteral nutrition.
Rannem T, Persson-Moschos M, Huang W, Staun M, Akesson B. Rannem T, et al. JPEN J Parenter Enteral Nutr. 1996 Jul-Aug;20(4):287-91. doi: 10.1177/0148607196020004287. JPEN J Parenter Enteral Nutr. 1996. PMID: 8865111 Clinical Trial.
Body composition in patients on home parenteral nutrition.
Tjellesen L, Staun M, Rannem T, Nielsen PK, Jarnum S. Tjellesen L, et al. Among authors: rannem t. Scand J Clin Lab Invest. 1996 Jul;56(4):295-303. doi: 10.3109/00365519609090580. Scand J Clin Lab Invest. 1996. PMID: 8837235
29 results